BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
29 results:

  • 1. Risk Factors of Positive Resection Margin in Hepatectomy for Resectable Ruptured Hepatocellular Carcinoma: Risk Prediction and prognosis.
    Xia F; Zhang Q; Zheng J; Huang Z; Ndhlovu E; Gao H
    J Gastrointest Surg; 2023 Jul; 27(7):1400-1411. PubMed ID: 37095336
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Venous Thromboembolism in Patients with Advanced pancreatic cancer Receiving Palliative Chemotherapy: Incidence and Effect on prognosis.
    Jeong HT; Bae JH; Kim HG; Han J
    Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis.
    Du F; Zhang L; Zhang Y; Fan H; Ren L
    Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102069. PubMed ID: 36513251
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
    Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Fabbri A; Prinzi N; Garzone G; Filugelli M; Pardo C; Mietta A; Pusceddu S; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
    Histopathology; 2023 Jan; 82(2):324-339. PubMed ID: 36239545
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
    Rosery V; Mika S; Schmid KW; Reis H; Stuschke M; Treckmann J; Markus P; Schumacher B; Albers D; Mende B; Lahner H; Wiesweg M; Schuler M; Siveke JT; Kasper S
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4315-4325. PubMed ID: 36071236
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer.
    Sakamoto T; Makinoya M; Sunaguchi T; Goto K; Morimoto M; Murakami Y; Miyatani K; Hanaki T; Shishido Y; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Fujiwara Y
    PLoS One; 2022; 17(7):e0271073. PubMed ID: 35797279
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of total laparoscopic versus open pancreaticoduodenectomy on short-term and oncological outcomes: a single-institution comparative study.
    Zhang P; Gong S; Wu N; Zhang C; Zhang Y; Zhang X; Ren Z
    Langenbecks Arch Surg; 2022 Nov; 407(7):2789-2799. PubMed ID: 35635585
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
    Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
    J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients.
    Ogushi K; Chuma M; Numata K; Nozaki A; Moriya S; Uojima H; Kondo M; Morimoto M; Maeda S
    Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):774-781. PubMed ID: 35102114
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Comparative clinical efficacy analysis of pancreatoduodenectomy for distal bile duct and pancreatic head cancer: a report of 1 005 cases].
    Wu PF; Zhang K; Lu ZP; Lin JZ; Chen JM; Xi CH; Wei JS; Guo F; Tu M; Jiang KR; Miao Y
    Zhonghua Wai Ke Za Zhi; 2022 Feb; 60(2):128-133. PubMed ID: 35012271
    [No Abstract]    [Full Text] [Related]  

  • 11. The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy.
    Takeda T; Sasaki T; Suzumori C; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
    Int J Clin Oncol; 2021 Jul; 26(7):1293-1303. PubMed ID: 33791917
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pretreatment biomarkers as prognostic predictors of survival in patients with pancreatic cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio
    Chen Y; Liao Y; Lam LM; He L; Tsang YS; Di YS; Liang ST; Xia Q
    Int J Med Sci; 2020; 17(10):1449-1457. PubMed ID: 32624701
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
    Kurahara H; Maemura K; Mataki Y; Tanoue K; Iino S; Kawasaki Y; Idichi T; Arigami T; Mori S; Shinden Y; Higashi M; Ueno S; Shinchi H; Natsugoe S
    Pancreatology; 2020 Jan; 20(1):89-94. PubMed ID: 31787525
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [A Case of Lung Metastasis Occurring Four Years after pancreaticoduodenectomy for pancreatic cancer].
    Yasui O; Kato Y; Oomoto T; Sasaki T; Takahashi T
    Gan To Kagaku Ryoho; 2019 Oct; 46(10):1581-1585. PubMed ID: 31631144
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma.
    Pankova D; Jiang Y; Chatzifrangkeskou M; Vendrell I; Buzzelli J; Ryan A; Brown C; O'Neill E
    EMBO J; 2019 Jul; 38(13):e100532. PubMed ID: 31268606
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of Weight Loss During Chemotherapy in Chinese Patients with Unresectable pancreatic cancer.
    Wong HCY; Lam KY; Chong CCN; Chan AWH; Chan SL
    Nutr Cancer; 2019; 71(6):954-970. PubMed ID: 31058551
    [No Abstract]    [Full Text] [Related]  

  • 17. [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].
    Cowppli-Bony A; Colonna M; Ligier K; Jooste V; Defossez G; Monnereau A; ;
    Bull Cancer; 2019; 106(7-8):617-634. PubMed ID: 30833045
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy.
    Kurita Y; Kobayashi N; Tokuhisa M; Goto A; Kubota K; Endo I; Nakajima A; Ichikawa Y
    Pancreatology; 2019 Jan; 19(1):127-135. PubMed ID: 30473464
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Current status of surgical treatment of gastric gastrointestinal tumors: a national multi-center retrospective study].
    Feng X; Li R; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Sun X; Yu J; Chen Z; Zhao Y; Liu X; Li J; Zhang B; Zhou Y; Huang C; Zhou Z; Li G; Tao K; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1258-1264. PubMed ID: 27928796
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
    Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
    Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.